Position in STTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,144,000
+$70,500 QoQ
Shares Held
800,000
-42.4% QoQ
Ownership
1.04%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026683 Capital Management, LLC holds $292,409,602 across 63 Biotechnology names. STTK ranks #13 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTGX |
Protagonist Therapeutics, Inc
|
355,000 | $37,417,000 | |
| 2 | WVE |
Wave Life Sciences Ltd.
|
4,900,000 | $35,525,000 | |
| 3 | ANAB |
Anaptysbio, Inc
|
625,000 | $34,662,468 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
2,450,000 | $21,217,000 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,553,500 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
590,000 | $19,599,800 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
750,000 | $16,320,000 | |
| 8 | ZVRA |
Zevra Therapeutics, Inc.
|
975,000 | $9,087,000 |
All Filings in STTK
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,144,000 | 800,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,073,500 | 1,390,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,661,996 | 1,532,216 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $867,240 | 1,095,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $997,500 | 1,050,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $1,270,500 | 1,050,000 | Shares | Defined | 2025-02-14 | |
| 2023-12-31 | $296,878 | 41,638 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||